Tuticorin Alkali Chemicals Fair Value
Tuticorin Alkali Chemicals (TUTIALKA) average fair value is ₹1402.89 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹56.56 (+2380.36%), fair value range ₹14.84–₹8177.54. Read TUTIALKA dividend yield for the complete payout history and dividend yield track record.
Fair Value Analysis Export
TUTIALKA Fair Value vs Current Price — Valuation Summary
TUTIALKA average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit TUTIALKA screener.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
TUTIALKA Fair Value Analysis — Data Sources & Coverage
Tuticorin Alkali Chemicals financial data sources, valuation methods applied and sector benchmarks used. Browse Tuticorin Alkali Chemicals annual reports for revenue, profit, balance sheet and cash flow data.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
TUTIALKA vs Chemicals Sector Peers — P/E, P/B & Market Cap
Tuticorin Alkali Chemicals P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Mehul Colours | MEHUL | 10.38 | 1.31 | ₹57 |
| National Fertilizers | NFL | 9.35 | 1.2 | ₹3,360 |
| Epigral | EPIGRAL | 10.84 | 1.74 | ₹3,648 |
| AG Ventures | AGVENTURES | 5.15 | 0.47 | ₹72 |
| PB Global | PBGLOBAL | -0.03 | 0.02 | ₹0 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.